People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kestrel Therapeutics Inc. | — | Biotechnology | Series A | $20.7M | $15.6M | 2021 |
Frank G. Haluska at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank G. Haluska on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nicholas G. Saccomano | 1 | 1 |
| Denis G. Patrick | 1 | 1 |
| Barbara G. Sosnowski | 1 | 1 |
| Omar G. Khalil | 1 | 1 |
| Andrew G. Phillips | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.